Stay updated on Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Sign up to get notified when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.

Latest updates to the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page
- Check6 days agoChange DetectedThe page history now shows a new revision entry: Revision: v3.3.2. This is a minor metadata update related to the revision history.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision v3.3.1 was added to the Study Record Versions, and Revision v3.2.0 was deleted.SummaryDifference0.1%

- Check20 days agoChange DetectedDeleted a general operating-status notice about government funding; it does not alter the study record or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check34 days agoChange DetectedVersion 2 (2019-06-11) updates the study record with a Recruitment Status change. This reflects a new enrollment status for the EARLY trial (NCT03750760).SummaryDifference0.1%

- Check63 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference13%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Early Alirocumab to Reduce LDL-C in Myocardial Infarction Clinical Trial page.